All News

Otezla has been found to improve the signs and symptoms of psoriatic arthritis.

CanChew Plus CBD Gum to be tested in irritable bowel syndrome clinical trial.

Nonsteroidal anti-inflammatory drugs effective in preventing advanced neoplasia recurrence.

Fenofibrate plus statin could provide a novel treatment option for patients with persistant high cholesterol.

Multiple clinical trials of vadastuximab talirine have been placed on clinical hold by the FDA.

Mylan has launched a generic version of Pfizer’s Cerebyx, an injectable variety of fosphenytoin sodium.

A United States District Court judge in Delaware granted Amgen's request for a permanent injunction prohibiting Sanofi/Regeneron from manufacturing, using, selling or offering their monoclonal antibodies to proprotein convertase subtilisin/kexin type 9 (PCSK9).

Antenatal ART significantly lowered early mother-to-child HIV transmission rates.

Treatment with atezolizumab more than doubled survival compared with chemotherapy.

Modafinil was seen to reduce impulsiveness, which is a major component of food addiction.

Combination therapy may help combat treatment resistance in cancer patients.

Genentech’s Lucentis granted fifth FDA approval.

Lucentis was recently approved to treat myopic choroidal neovascularization.

Top articles of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

The FDA approved the lowest amount of new drugs since 2010 last year, with only 22 new drugs receiving approval.

The survey found 65.5% of veterans experienced pain within the past 3 months.

ASN003 is a drug that targets cancers driven by BRAF and PI3K.

Top news of the day from across the healthcare landscape.

HIV drug trial will evaluate cabotegravir’s performance as a pre-exposure prophylaxis.

ASN003 demonstrated potent action against tumor growth.

New guidelines emphasize the early introduction of peanut-containing foods to infants.

Learn about the new products and expanded indications approved by the FDA in December 2016.

The ivWatch Model 400 for pediatric patients is now available in the United States.

The FDA only approved 22 new drugs in 2016, the lowest amount in years.

The FDA only approved 22 new drugs in 2016, the lowest amount in years.

A new report discusses how much the ACA repeal may cost and save the United States.

The Aptima HIV-1 Quant assay will significantly cut lab times.

Hispanic newborns that develop acute lymphoblastic leukemia are 5.9% times more likely to have a cytomegalovirus infection at birth.

Group-based acceptance and commitment therapy increased likelihood of effective coping strategies in diabetes patients.